Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Denise Niewerth, Gertjan J. L. Kaspers, Gerrit Jansen, Johan van Meerloo, Sonja Zweegman, Gaye Jenkins, James A. Whitlock, Stephen P. Hunger, Xiaomin Lu, Todd A. Alonzo, Peter M. van de Ven, Terzah M. Horton, Jacqueline Cloos

ABSTRACT

BACKGROUND: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL). METHODS: We investigated whether expression ratios of immunoproteasome to constitutive proteasome in leukaemic cells correlated with response to bortezomib-containing re-induction chemotherapy in patients with relapsed and refractory acute leukaemia, enrolled in two Children's Oncology Group phase 2 trials of bortezomib for ALL (COG-AALL07P1) and AML (COG-AAML07P1). Expression of proteasome subunits was examined in 72 patient samples (ALL n = 60, AML n = 12) obtained before start of therapy. Statistical significance between groups was determined by Mann-Whitney U test. RESULTS: Ratios of immunoproteasome to constitutive proteasome subunit expression were significantly higher in pre-B ALL cells than in AML cells for both β5i/β5 and β1i/β1 subunits (p = 0.004 and p < 0.001). These ratios correlated with therapy response in AML patients; β1i/β1 ratios were significantly higher (p = 0.028) between patients who did (n = 4) and did not reach complete remission (CR) (n = 8), although for β5i/β5 ratios, this did not reach significance. For ALL patients, the subunit ratios were also higher for patients who showed a good early response to therapy but this relation was not statistically significant. Overall, for this study, the patients were treated with combination therapy, so response was not only attributed to proteasome inhibition. Moreover, the leukaemic blast cells were not purified for these samples. CONCLUSIONS: These first ex vivo results encourage further studies into relative proteasome subunit expression to improve proteasome inhibition-containing therapy and as a potential indicator of bortezomib response in acute leukaemia. More... »

PAGES

82

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13045-016-0312-z

DOI

http://dx.doi.org/10.1186/s13045-016-0312-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027910018

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27599459


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Specimen Collection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bortezomib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteasome Endopeptidase Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteasome Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Subunits", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niewerth", 
        "givenName": "Denise", 
        "id": "sg:person.01026513273.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026513273.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaspers", 
        "givenName": "Gertjan J. L.", 
        "id": "sg:person.014154361037.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014154361037.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Amsterdam Rheumatology & Immunology Center, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jansen", 
        "givenName": "Gerrit", 
        "id": "sg:person.01273433134.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273433134.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands", 
            "Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Meerloo", 
        "givenName": "Johan", 
        "id": "sg:person.01106707663.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106707663.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zweegman", 
        "givenName": "Sonja", 
        "id": "sg:person.01110171530.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110171530.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Department of Pediatrics, Texas Children\u2019s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jenkins", 
        "givenName": "Gaye", 
        "id": "sg:person.01014526302.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014526302.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whitlock", 
        "givenName": "James A.", 
        "id": "sg:person.01053057361.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053057361.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Colorado Denver", 
          "id": "https://www.grid.ac/institutes/grid.241116.1", 
          "name": [
            "Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hunger", 
        "givenName": "Stephen P.", 
        "id": "sg:person.01362474423.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362474423.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Children's Oncology Group", 
          "id": "https://www.grid.ac/institutes/grid.428204.8", 
          "name": [
            "COG Operations Office, Arcadia, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Xiaomin", 
        "id": "sg:person.0637070323.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637070323.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Southern California", 
          "id": "https://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alonzo", 
        "givenName": "Todd A.", 
        "id": "sg:person.01161017722.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161017722.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van de Ven", 
        "givenName": "Peter M.", 
        "id": "sg:person.0647042767.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647042767.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Department of Pediatrics, Texas Children\u2019s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horton", 
        "givenName": "Terzah M.", 
        "id": "sg:person.01137314223.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137314223.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands", 
            "Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cloos", 
        "givenName": "Jacqueline", 
        "id": "sg:person.0576735634.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576735634.67"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-319-06752-0_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002377553", 
          "https://doi.org/10.1007/978-3-319-06752-0_2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.25117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002833909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-08-3531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003212965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-07-2911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004001373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.9665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005595084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2011.256", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005952313", 
          "https://doi.org/10.1038/leu.2011.256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri2687", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006095139", 
          "https://doi.org/10.1038/nri2687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri2687", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006095139", 
          "https://doi.org/10.1038/nri2687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-4626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006435466"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-05-223677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008565687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-7-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008737572", 
          "https://doi.org/10.1186/1756-8722-7-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2008.04.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013765937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-05-426924", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014922275"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-08-104950", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015039653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.coi.2012.11.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019630757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019902180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2005.06.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021021108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj20100383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021521474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj20100383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021521474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-05-378943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022136944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/anie.201509092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022473207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024058742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-006-0367-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024291543", 
          "https://doi.org/10.1007/s00280-006-0367-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-006-0367-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024291543", 
          "https://doi.org/10.1007/s00280-006-0367-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2011.09.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025999556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-005-0135-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026328818", 
          "https://doi.org/10.1007/s00280-005-0135-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-005-0135-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026328818", 
          "https://doi.org/10.1007/s00280-005-0135-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-03-0508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026446125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028516049"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v98.8.2301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030060903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2011.196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031416563", 
          "https://doi.org/10.1038/leu.2011.196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/era.12.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031437145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2013.092411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031927437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clml.2011.06.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033361356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-04-403733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034167280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034785812", 
          "https://doi.org/10.1038/sj.leu.2404414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034785812", 
          "https://doi.org/10.1038/sj.leu.2404414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401705", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034911840", 
          "https://doi.org/10.1038/sj.leu.2401705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401705", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034911840", 
          "https://doi.org/10.1038/sj.leu.2401705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drup.2014.12.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039753701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-04-418640", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042150781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-06752-0_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044759535", 
          "https://doi.org/10.1007/978-3-319-06752-0_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drup.2008.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046678406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-03-413898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049230850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.21214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049380687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.21214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049380687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076860446", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL).\nMETHODS: We investigated whether expression ratios of immunoproteasome to constitutive proteasome in leukaemic cells correlated with response to bortezomib-containing re-induction chemotherapy in patients with relapsed and refractory acute leukaemia, enrolled in two Children's Oncology Group phase 2 trials of bortezomib for ALL (COG-AALL07P1) and AML (COG-AAML07P1). Expression of proteasome subunits was examined in 72 patient samples (ALL n\u2009=\u200960, AML n\u2009=\u200912) obtained before start of therapy. Statistical significance between groups was determined by Mann-Whitney U test.\nRESULTS: Ratios of immunoproteasome to constitutive proteasome subunit expression were significantly higher in pre-B ALL cells than in AML cells for both \u03b25i/\u03b25 and \u03b21i/\u03b21 subunits (p\u2009=\u20090.004 and p\u2009<\u20090.001). These ratios correlated with therapy response in AML patients; \u03b21i/\u03b21 ratios were significantly higher (p\u2009=\u20090.028) between patients who did (n\u2009=\u20094) and did not reach complete remission (CR) (n\u2009=\u20098), although for \u03b25i/\u03b25 ratios, this did not reach significance. For ALL patients, the subunit ratios were also higher for patients who showed a good early response to therapy but this relation was not statistically significant. Overall, for this study, the patients were treated with combination therapy, so response was not only attributed to proteasome inhibition. Moreover, the leukaemic blast cells were not purified for these samples.\nCONCLUSIONS: These first ex vivo results encourage further studies into relative proteasome subunit expression to improve proteasome inhibition-containing therapy and as a potential indicator of bortezomib response in acute leukaemia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13045-016-0312-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2693699", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3535922", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2418440", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693700", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1039771", 
        "issn": [
          "1756-8722"
        ], 
        "name": "Journal of Hematology & Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy", 
    "pagination": "82", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "84f44e55889cca213b7d22ad9cedc7386d18a23a3c3a9fdc092b87132cf9bd62"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27599459"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101468937"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13045-016-0312-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027910018"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13045-016-0312-z", 
      "https://app.dimensions.ai/details/publication/pub.1027910018"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70028_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13045-016-0312-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13045-016-0312-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13045-016-0312-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13045-016-0312-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13045-016-0312-z'


 

This table displays all metadata directly associated to this object as RDF triples.

387 TRIPLES      21 PREDICATES      89 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13045-016-0312-z schema:about N13482e93513943d2ab7cf86852a34da9
2 N1bc733276d9a4a2591fc61a6a5bf193e
3 N1e90b6f330e9456a8fd21fb8942e7051
4 N32e1e3d174ce482ca942e71a705e0251
5 N56f157eb1c154de7a8ac427e1ae000ac
6 N5fe60b10a9fb42abb0d927e5e8235fa5
7 N605ee1ed44ab4266b63a47f8db86c1ad
8 N81dccf9a0d284fb99e8e4519b90c27a8
9 N87d065f9d62f451c8552705d6adff09f
10 N9514759659f04f9cab9b05c771c83353
11 N967728613ddd4aba9da08580fac8374f
12 N9cef120532a54ace95c12b65bfb51ce1
13 N9ec334ece1834cb6b90fc98da57259db
14 Nb3f2f41ef5d84b60897c08c478ff0f98
15 Nc3544f7aa7b84d278c37c0d15b32b7e6
16 Ne47a32a06e8846378e91b94ea266ddb8
17 Nf131817e966b4287b5ce2bb2b55d0048
18 Nf592a4026e3c4e85abd326ea99abd363
19 Nf8bd43217ec44f90af643df7766bed19
20 Nfeec48d92e894c2dbb72b196321a72cc
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N85b2e9dc8df5497a80fe0afea377a432
24 schema:citation sg:pub.10.1007/978-3-319-06752-0_2
25 sg:pub.10.1007/978-3-319-06752-0_7
26 sg:pub.10.1007/s00280-005-0135-z
27 sg:pub.10.1007/s00280-006-0367-6
28 sg:pub.10.1038/leu.2011.196
29 sg:pub.10.1038/leu.2011.256
30 sg:pub.10.1038/nri2687
31 sg:pub.10.1038/sj.leu.2401705
32 sg:pub.10.1038/sj.leu.2404414
33 sg:pub.10.1186/1756-8722-7-7
34 https://app.dimensions.ai/details/publication/pub.1076860446
35 https://doi.org/10.1002/anie.201509092
36 https://doi.org/10.1002/cncr.22097
37 https://doi.org/10.1002/cncr.23224
38 https://doi.org/10.1002/pbc.21214
39 https://doi.org/10.1002/pbc.25117
40 https://doi.org/10.1016/j.clml.2011.06.004
41 https://doi.org/10.1016/j.coi.2012.11.004
42 https://doi.org/10.1016/j.drup.2008.08.002
43 https://doi.org/10.1016/j.drup.2014.12.001
44 https://doi.org/10.1016/j.exphem.2008.04.013
45 https://doi.org/10.1016/j.exphem.2011.09.003
46 https://doi.org/10.1016/j.leukres.2005.06.014
47 https://doi.org/10.1042/bj20100383
48 https://doi.org/10.1158/1078-0432.ccr-03-0508
49 https://doi.org/10.1158/1078-0432.ccr-06-2173
50 https://doi.org/10.1158/1078-0432.ccr-07-4626
51 https://doi.org/10.1182/blood-2004-07-2911
52 https://doi.org/10.1182/blood-2005-08-3531
53 https://doi.org/10.1182/blood-2007-08-104950
54 https://doi.org/10.1182/blood-2009-05-223677
55 https://doi.org/10.1182/blood-2012-03-413898
56 https://doi.org/10.1182/blood-2012-04-403733
57 https://doi.org/10.1182/blood-2012-04-418640
58 https://doi.org/10.1182/blood-2012-05-378943
59 https://doi.org/10.1182/blood-2012-05-426924
60 https://doi.org/10.1182/blood.v98.8.2301
61 https://doi.org/10.1200/jco.2006.07.9665
62 https://doi.org/10.1586/era.12.1
63 https://doi.org/10.3324/haematol.2013.092411
64 schema:datePublished 2016-12
65 schema:datePublishedReg 2016-12-01
66 schema:description BACKGROUND: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL). METHODS: We investigated whether expression ratios of immunoproteasome to constitutive proteasome in leukaemic cells correlated with response to bortezomib-containing re-induction chemotherapy in patients with relapsed and refractory acute leukaemia, enrolled in two Children's Oncology Group phase 2 trials of bortezomib for ALL (COG-AALL07P1) and AML (COG-AAML07P1). Expression of proteasome subunits was examined in 72 patient samples (ALL n = 60, AML n = 12) obtained before start of therapy. Statistical significance between groups was determined by Mann-Whitney U test. RESULTS: Ratios of immunoproteasome to constitutive proteasome subunit expression were significantly higher in pre-B ALL cells than in AML cells for both β5i/β5 and β1i/β1 subunits (p = 0.004 and p < 0.001). These ratios correlated with therapy response in AML patients; β1i/β1 ratios were significantly higher (p = 0.028) between patients who did (n = 4) and did not reach complete remission (CR) (n = 8), although for β5i/β5 ratios, this did not reach significance. For ALL patients, the subunit ratios were also higher for patients who showed a good early response to therapy but this relation was not statistically significant. Overall, for this study, the patients were treated with combination therapy, so response was not only attributed to proteasome inhibition. Moreover, the leukaemic blast cells were not purified for these samples. CONCLUSIONS: These first ex vivo results encourage further studies into relative proteasome subunit expression to improve proteasome inhibition-containing therapy and as a potential indicator of bortezomib response in acute leukaemia.
67 schema:genre research_article
68 schema:inLanguage en
69 schema:isAccessibleForFree true
70 schema:isPartOf N0aa02ca72db249c89d95abc3f5c77d4e
71 N79f9b14586c34c82aba5a35fd3f5206b
72 sg:journal.1039771
73 schema:name Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
74 schema:pagination 82
75 schema:productId N0224ef0773fe4adb818f38db59f5e3cc
76 N0e1c4e390cea4d478e1646e5356bba09
77 N3732b7bcd6a14717a69d55351f05021c
78 N86d33c0b6ec34bac81b2cac1e67d91e2
79 N89603215310a475db868ae7fe9bccf1f
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027910018
81 https://doi.org/10.1186/s13045-016-0312-z
82 schema:sdDatePublished 2019-04-11T12:35
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher Ne86d98b279364c4d9a19a08b59feb276
85 schema:url https://link.springer.com/10.1186%2Fs13045-016-0312-z
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N0224ef0773fe4adb818f38db59f5e3cc schema:name nlm_unique_id
90 schema:value 101468937
91 rdf:type schema:PropertyValue
92 N0aa02ca72db249c89d95abc3f5c77d4e schema:volumeNumber 9
93 rdf:type schema:PublicationVolume
94 N0e1c4e390cea4d478e1646e5356bba09 schema:name dimensions_id
95 schema:value pub.1027910018
96 rdf:type schema:PropertyValue
97 N13482e93513943d2ab7cf86852a34da9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Protein Subunits
99 rdf:type schema:DefinedTerm
100 N154e31d73059470cb88ba677b273b588 rdf:first sg:person.01137314223.14
101 rdf:rest N9f85ac77ad644655825c2da9c60f9633
102 N1bc733276d9a4a2591fc61a6a5bf193e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Male
104 rdf:type schema:DefinedTerm
105 N1e90b6f330e9456a8fd21fb8942e7051 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Adolescent
107 rdf:type schema:DefinedTerm
108 N1f947d4639994eb6bccc73b771fb7ffd rdf:first sg:person.0647042767.19
109 rdf:rest N154e31d73059470cb88ba677b273b588
110 N328ffb422c874bf8b6cc5a8e51f79bbc rdf:first sg:person.01273433134.01
111 rdf:rest N9c935026016d44fb92fd25c89466023e
112 N32e1e3d174ce482ca942e71a705e0251 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Female
114 rdf:type schema:DefinedTerm
115 N3382d1e139494545b8b04bcb654eb857 rdf:first sg:person.01053057361.68
116 rdf:rest Nd3361dfd9af34ebcaf55413d2f813849
117 N3732b7bcd6a14717a69d55351f05021c schema:name pubmed_id
118 schema:value 27599459
119 rdf:type schema:PropertyValue
120 N550a4678210b451a8e0ded496e1fb07f rdf:first sg:person.01110171530.57
121 rdf:rest Nbcec19ed69cd467695182f159a4e1077
122 N56f157eb1c154de7a8ac427e1ae000ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Proteasome Endopeptidase Complex
124 rdf:type schema:DefinedTerm
125 N5fe60b10a9fb42abb0d927e5e8235fa5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Child
127 rdf:type schema:DefinedTerm
128 N605ee1ed44ab4266b63a47f8db86c1ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Precursor Cell Lymphoblastic Leukemia-Lymphoma
130 rdf:type schema:DefinedTerm
131 N65cad0e0e36b4453a2c4a89d5e6b59fe rdf:first sg:person.01161017722.34
132 rdf:rest N1f947d4639994eb6bccc73b771fb7ffd
133 N66db6b89052548cfb92582b5489f9872 rdf:first sg:person.0637070323.98
134 rdf:rest N65cad0e0e36b4453a2c4a89d5e6b59fe
135 N79f9b14586c34c82aba5a35fd3f5206b schema:issueNumber 1
136 rdf:type schema:PublicationIssue
137 N81dccf9a0d284fb99e8e4519b90c27a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Biopsy
139 rdf:type schema:DefinedTerm
140 N85b2e9dc8df5497a80fe0afea377a432 rdf:first sg:person.01026513273.59
141 rdf:rest Ndbbd4ac890a549bca7d2d6934e446c46
142 N86d33c0b6ec34bac81b2cac1e67d91e2 schema:name doi
143 schema:value 10.1186/s13045-016-0312-z
144 rdf:type schema:PropertyValue
145 N87d065f9d62f451c8552705d6adff09f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Bortezomib
147 rdf:type schema:DefinedTerm
148 N89603215310a475db868ae7fe9bccf1f schema:name readcube_id
149 schema:value 84f44e55889cca213b7d22ad9cedc7386d18a23a3c3a9fdc092b87132cf9bd62
150 rdf:type schema:PropertyValue
151 N9514759659f04f9cab9b05c771c83353 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Blood Specimen Collection
153 rdf:type schema:DefinedTerm
154 N967728613ddd4aba9da08580fac8374f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Immunoproteins
156 rdf:type schema:DefinedTerm
157 N9c935026016d44fb92fd25c89466023e rdf:first sg:person.01106707663.95
158 rdf:rest N550a4678210b451a8e0ded496e1fb07f
159 N9cef120532a54ace95c12b65bfb51ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Recurrence
161 rdf:type schema:DefinedTerm
162 N9ec334ece1834cb6b90fc98da57259db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Treatment Outcome
164 rdf:type schema:DefinedTerm
165 N9f85ac77ad644655825c2da9c60f9633 rdf:first sg:person.0576735634.67
166 rdf:rest rdf:nil
167 Nb3f2f41ef5d84b60897c08c478ff0f98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Antineoplastic Combined Chemotherapy Protocols
169 rdf:type schema:DefinedTerm
170 Nbcec19ed69cd467695182f159a4e1077 rdf:first sg:person.01014526302.41
171 rdf:rest N3382d1e139494545b8b04bcb654eb857
172 Nc3544f7aa7b84d278c37c0d15b32b7e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Infant
174 rdf:type schema:DefinedTerm
175 Nd3361dfd9af34ebcaf55413d2f813849 rdf:first sg:person.01362474423.61
176 rdf:rest N66db6b89052548cfb92582b5489f9872
177 Ndbbd4ac890a549bca7d2d6934e446c46 rdf:first sg:person.014154361037.28
178 rdf:rest N328ffb422c874bf8b6cc5a8e51f79bbc
179 Ne47a32a06e8846378e91b94ea266ddb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Humans
181 rdf:type schema:DefinedTerm
182 Ne86d98b279364c4d9a19a08b59feb276 schema:name Springer Nature - SN SciGraph project
183 rdf:type schema:Organization
184 Nf131817e966b4287b5ce2bb2b55d0048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Prognosis
186 rdf:type schema:DefinedTerm
187 Nf592a4026e3c4e85abd326ea99abd363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Leukemia, Myeloid, Acute
189 rdf:type schema:DefinedTerm
190 Nf8bd43217ec44f90af643df7766bed19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Proteasome Inhibitors
192 rdf:type schema:DefinedTerm
193 Nfeec48d92e894c2dbb72b196321a72cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Young Adult
195 rdf:type schema:DefinedTerm
196 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
197 schema:name Medical and Health Sciences
198 rdf:type schema:DefinedTerm
199 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
200 schema:name Oncology and Carcinogenesis
201 rdf:type schema:DefinedTerm
202 sg:grant.2418440 http://pending.schema.org/fundedItem sg:pub.10.1186/s13045-016-0312-z
203 rdf:type schema:MonetaryGrant
204 sg:grant.2693699 http://pending.schema.org/fundedItem sg:pub.10.1186/s13045-016-0312-z
205 rdf:type schema:MonetaryGrant
206 sg:grant.2693700 http://pending.schema.org/fundedItem sg:pub.10.1186/s13045-016-0312-z
207 rdf:type schema:MonetaryGrant
208 sg:grant.3535922 http://pending.schema.org/fundedItem sg:pub.10.1186/s13045-016-0312-z
209 rdf:type schema:MonetaryGrant
210 sg:journal.1039771 schema:issn 1756-8722
211 schema:name Journal of Hematology & Oncology
212 rdf:type schema:Periodical
213 sg:person.01014526302.41 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
214 schema:familyName Jenkins
215 schema:givenName Gaye
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014526302.41
217 rdf:type schema:Person
218 sg:person.01026513273.59 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
219 schema:familyName Niewerth
220 schema:givenName Denise
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026513273.59
222 rdf:type schema:Person
223 sg:person.01053057361.68 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
224 schema:familyName Whitlock
225 schema:givenName James A.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053057361.68
227 rdf:type schema:Person
228 sg:person.01106707663.95 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
229 schema:familyName van Meerloo
230 schema:givenName Johan
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106707663.95
232 rdf:type schema:Person
233 sg:person.01110171530.57 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
234 schema:familyName Zweegman
235 schema:givenName Sonja
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110171530.57
237 rdf:type schema:Person
238 sg:person.01137314223.14 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
239 schema:familyName Horton
240 schema:givenName Terzah M.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137314223.14
242 rdf:type schema:Person
243 sg:person.01161017722.34 schema:affiliation https://www.grid.ac/institutes/grid.42505.36
244 schema:familyName Alonzo
245 schema:givenName Todd A.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161017722.34
247 rdf:type schema:Person
248 sg:person.01273433134.01 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
249 schema:familyName Jansen
250 schema:givenName Gerrit
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273433134.01
252 rdf:type schema:Person
253 sg:person.01362474423.61 schema:affiliation https://www.grid.ac/institutes/grid.241116.1
254 schema:familyName Hunger
255 schema:givenName Stephen P.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362474423.61
257 rdf:type schema:Person
258 sg:person.014154361037.28 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
259 schema:familyName Kaspers
260 schema:givenName Gertjan J. L.
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014154361037.28
262 rdf:type schema:Person
263 sg:person.0576735634.67 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
264 schema:familyName Cloos
265 schema:givenName Jacqueline
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576735634.67
267 rdf:type schema:Person
268 sg:person.0637070323.98 schema:affiliation https://www.grid.ac/institutes/grid.428204.8
269 schema:familyName Lu
270 schema:givenName Xiaomin
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637070323.98
272 rdf:type schema:Person
273 sg:person.0647042767.19 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
274 schema:familyName van de Ven
275 schema:givenName Peter M.
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647042767.19
277 rdf:type schema:Person
278 sg:pub.10.1007/978-3-319-06752-0_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002377553
279 https://doi.org/10.1007/978-3-319-06752-0_2
280 rdf:type schema:CreativeWork
281 sg:pub.10.1007/978-3-319-06752-0_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044759535
282 https://doi.org/10.1007/978-3-319-06752-0_7
283 rdf:type schema:CreativeWork
284 sg:pub.10.1007/s00280-005-0135-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1026328818
285 https://doi.org/10.1007/s00280-005-0135-z
286 rdf:type schema:CreativeWork
287 sg:pub.10.1007/s00280-006-0367-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024291543
288 https://doi.org/10.1007/s00280-006-0367-6
289 rdf:type schema:CreativeWork
290 sg:pub.10.1038/leu.2011.196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031416563
291 https://doi.org/10.1038/leu.2011.196
292 rdf:type schema:CreativeWork
293 sg:pub.10.1038/leu.2011.256 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005952313
294 https://doi.org/10.1038/leu.2011.256
295 rdf:type schema:CreativeWork
296 sg:pub.10.1038/nri2687 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006095139
297 https://doi.org/10.1038/nri2687
298 rdf:type schema:CreativeWork
299 sg:pub.10.1038/sj.leu.2401705 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034911840
300 https://doi.org/10.1038/sj.leu.2401705
301 rdf:type schema:CreativeWork
302 sg:pub.10.1038/sj.leu.2404414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034785812
303 https://doi.org/10.1038/sj.leu.2404414
304 rdf:type schema:CreativeWork
305 sg:pub.10.1186/1756-8722-7-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008737572
306 https://doi.org/10.1186/1756-8722-7-7
307 rdf:type schema:CreativeWork
308 https://app.dimensions.ai/details/publication/pub.1076860446 schema:CreativeWork
309 https://doi.org/10.1002/anie.201509092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022473207
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1002/cncr.22097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024058742
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1002/cncr.23224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019902180
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1002/pbc.21214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049380687
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1002/pbc.25117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002833909
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1016/j.clml.2011.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033361356
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1016/j.coi.2012.11.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019630757
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1016/j.drup.2008.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046678406
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1016/j.drup.2014.12.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039753701
326 rdf:type schema:CreativeWork
327 https://doi.org/10.1016/j.exphem.2008.04.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013765937
328 rdf:type schema:CreativeWork
329 https://doi.org/10.1016/j.exphem.2011.09.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025999556
330 rdf:type schema:CreativeWork
331 https://doi.org/10.1016/j.leukres.2005.06.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021021108
332 rdf:type schema:CreativeWork
333 https://doi.org/10.1042/bj20100383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021521474
334 rdf:type schema:CreativeWork
335 https://doi.org/10.1158/1078-0432.ccr-03-0508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026446125
336 rdf:type schema:CreativeWork
337 https://doi.org/10.1158/1078-0432.ccr-06-2173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028516049
338 rdf:type schema:CreativeWork
339 https://doi.org/10.1158/1078-0432.ccr-07-4626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006435466
340 rdf:type schema:CreativeWork
341 https://doi.org/10.1182/blood-2004-07-2911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004001373
342 rdf:type schema:CreativeWork
343 https://doi.org/10.1182/blood-2005-08-3531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003212965
344 rdf:type schema:CreativeWork
345 https://doi.org/10.1182/blood-2007-08-104950 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015039653
346 rdf:type schema:CreativeWork
347 https://doi.org/10.1182/blood-2009-05-223677 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008565687
348 rdf:type schema:CreativeWork
349 https://doi.org/10.1182/blood-2012-03-413898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049230850
350 rdf:type schema:CreativeWork
351 https://doi.org/10.1182/blood-2012-04-403733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034167280
352 rdf:type schema:CreativeWork
353 https://doi.org/10.1182/blood-2012-04-418640 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042150781
354 rdf:type schema:CreativeWork
355 https://doi.org/10.1182/blood-2012-05-378943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022136944
356 rdf:type schema:CreativeWork
357 https://doi.org/10.1182/blood-2012-05-426924 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014922275
358 rdf:type schema:CreativeWork
359 https://doi.org/10.1182/blood.v98.8.2301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030060903
360 rdf:type schema:CreativeWork
361 https://doi.org/10.1200/jco.2006.07.9665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005595084
362 rdf:type schema:CreativeWork
363 https://doi.org/10.1586/era.12.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031437145
364 rdf:type schema:CreativeWork
365 https://doi.org/10.3324/haematol.2013.092411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031927437
366 rdf:type schema:CreativeWork
367 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
368 schema:name Department of Amsterdam Rheumatology & Immunology Center, VU University Medical Center, Amsterdam, The Netherlands
369 Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
370 Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
371 Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands
372 rdf:type schema:Organization
373 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
374 schema:name Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada
375 rdf:type schema:Organization
376 https://www.grid.ac/institutes/grid.241116.1 schema:alternateName University of Colorado Denver
377 schema:name Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA
378 rdf:type schema:Organization
379 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
380 schema:name Department of Pediatrics, Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA
381 rdf:type schema:Organization
382 https://www.grid.ac/institutes/grid.42505.36 schema:alternateName University of Southern California
383 schema:name Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
384 rdf:type schema:Organization
385 https://www.grid.ac/institutes/grid.428204.8 schema:alternateName Children's Oncology Group
386 schema:name COG Operations Office, Arcadia, CA, USA
387 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...